|
Fung, H L; Booth, B P; Tabrizi-Fard, M (1999) Therapeutics of nitric oxide modulation. Met Ions Biol Syst 36:723-49
|
|
Booth, B P; Fung, H L (1998) Contribution of vascular tissue to the antiplatelet activity of sodium nitroprusside. J Cardiovasc Pharmacol 32:129-33
|
|
Booth, B P; Nolan, T D; Fung, H L (1997) Nitroglycerin-inhibited whole blood aggregation is partially mediated by calcitonin gene-related peptide -- a neurogenic mechanism. Br J Pharmacol 122:577-83
|
|
Bauer, J A; Nolan, T; Fung, H L (1997) Vascular and hemodynamic differences between organic nitrates and nitrites. J Pharmacol Exp Ther 280:326-31
|
|
Bauer, J A; Balthasar, J P; Fung, H L (1997) Application of pharmacodynamic modeling for designing time-variant dosing regimens to overcome nitroglycerin tolerance in experimental heart failure. Pharm Res 14:1140-5
|
|
Booth, B P; Jacob, S; Bauer, J A et al. (1996) Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats. J Cardiovasc Pharmacol 28:432-8
|
|
Bauer, J A; Booth, B P; Fung, H L (1995) Nitric oxide donors: biochemical pharmacology and therapeutics. Adv Pharmacol 34:361-81
|
|
Bangalore, R; Triggle, D J (1995) Age-dependent changes in voltage-gated calcium channels and ATP-dependent potassium channels in Fischer 344 rats. Gen Pharmacol 26:1237-42
|
|
Liu, J; Bangalore, R; Rutledge, A et al. (1994) Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization. Mol Pharmacol 45:1198-206
|
|
Bachert, E L; Li, Z W; Zhao, L et al. (1994) A modified product inhibition model describes the nonlinear pharmacokinetics of nicorandil in rats. Pharm Res 11:1190-8
|
Showing the most recent 10 out of 48 publications
